A clinical research study is comparing an established treatment given through a vein with the same treatment given under the skin in adults with active psoriatic arthritis or axial spondyloarthritis.
Psoriatic Arthritis and Axial Spondyloarthritis Clinical Trials
When Psoriatic Arthritis or Axial Spondyloarthritis Affects Daily Life
Living with psoriatic arthritis or axial spondyloarthritis can mean carrying pain and stiffness into everyday moments. Getting out of bed, moving after sitting, staying active, or keeping up with the things you enjoy can become harder when inflammation affects your joints or spine. For some people, fatigue and limited movement add to the challenge.
Psoriatic arthritis (PsA) is a type of inflammatory arthritis that causes joint pain, swelling, and stiffness. Axial spondyloarthritis (axSpA) mainly affects the spine and pelvis, often causing long-term back pain and stiffness. Because these conditions can have such a real impact, these psoriatic arthritis clinical trials can help researchers learn how treatment can be given in ways that may be fit for people living with joint and spine inflammation.
"*" indicates required fields
Arthritis And Spine Inflammation Studies: Exploring Different Ways to Receive Treatment
These psoriatic arthritis and axial spondyloarthritis clinical trials in Richardson, Texas are comparing two ways of receiving the same established treatment: intravenously (IV), directly into a vein, or subcutaneously (SC), as an injection under the skin. Researchers want to know whether both methods result in similar amounts of medicine in the body. What they learn may help guide how this treatment is given in the future.
Participants are randomly assigned to one of the two treatment groups. Throughout the study, the research team will check your health regularly and take blood samples to see how the medicine moves through your body over time.
- Study-related treatment, care, and tests at no cost
- Regular health check-ins and assessments
- Compensation for time and travel may be available